G Ribizzi

Summary

Country: Italy

Publications

  1. pmc Clinical baseline factors predict response to natalizumab: their usefulness in patient selection
    Alice Laroni
    Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132 Genova, Italy
    BMC Neurol 14:103. 2014
  2. ncbi request reprint Cytokine polymorphisms and Alzheimer disease: possible associations
    G Ribizzi
    Department of Neurology, Ospedale S Martino, L go R Benzi, 10, 16100, Genoa, Italy
    Neurol Sci 31:321-5. 2010

Collaborators

  • E Ferrari
  • Alice Laroni
  • Ilaria Gandoglia
  • Elisabetta Capello
  • Tiziana Tassinari
  • Antonio Uccelli
  • Simonetta Venturi
  • Matteo Pizzorno
  • Claudio Solaro
  • Giovanna Baldassarre
  • Maria Teresa Rilla
  • Maria Pia Sormani
  • Sergio Parodi
  • Giovanni Luigi Mancardi

Detail Information

Publications2

  1. pmc Clinical baseline factors predict response to natalizumab: their usefulness in patient selection
    Alice Laroni
    Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Largo Daneo 3, 16132 Genova, Italy
    BMC Neurol 14:103. 2014
    ..Optimal patient selection would improve the risk-benefit ratio of natalizumab treatment for relapsing-remitting multiple sclerosis (RR MS). Clinical features of subjects responding to natalizumab have not been univocally recognized...
  2. ncbi request reprint Cytokine polymorphisms and Alzheimer disease: possible associations
    G Ribizzi
    Department of Neurology, Ospedale S Martino, L go R Benzi, 10, 16100, Genoa, Italy
    Neurol Sci 31:321-5. 2010
    ..Large cohort studies are necessary in order to assess the real association of some cytokine alleles or haplotypes with AD...